Unregistered User If this is not your name, click here.
		Contact Us | Order Now | Journals | Bookstore | Register a colleague
	Select a ChannelAcneAIDS and HIVAllergy OtherAlzheimer'sAnaesthesiology OtherAngina Pectoris/MIAnxietyArthritis OtherAsthmaBack PainBacterial InfectionsBladder CancerBone Marrow TransplantationBreast CancerCardiology OtherCataractCell TransplantationCervical CancerCholesterol/Lipid disordersCirrhosisClinical PharmacologyColorectal CancerCongestive Heart FailureContact DermatitisContraceptionCOPDCystic FibrosisDental and Oral DisordersDepressionDermatology OtherDiabetesDialysisEating DisordersElbowEmergency MedicineEndocrinology OtherEpilepsyErectile DysfunctionFibromyalgiaGastro OtherGeneticsGenitourinary OtherGeriatricsGERD/GastritisGlaucomaH. Pylori/UlcerHaematology OtherHair LossHeadachesHepa/Biliary OtherHepatitisHipHRTHypertensionIBDImmunologyInfectious OtherInfertilityIntensive CareIrritable Bowel SyndromeKneeLeukemiasLiver CancerLung CancerLupusLymphomasMelanomaMenopauseMultiple Sclerosis Nephrology OtherNeurologic OtherNutritional / Metabolic OtherOb/Gyn OtherObesityOncology OtherOphth. OtherOphthalmic SurgeryOrgan TransplantationOrthopaedics OtherOsteoarthritisOsteoporosisOtitisOtorhino. OtherOvarian CancerPaediatricsPainPancreatic CancerParkinson'sPregnancyProstate CancerPsychiatry OtherPulmonary OtherRadiologyRenal CancerRenal FailureRespiratory InfectionsRheumatoid arthritisRheumatology OtherRhinitisSchizophreniaShoulderSleep ApnoeaSleep DisordersSpineStrokeSTDsSurgeryThyroid DisordersTransfusionTransplant Surgery OtherTraumaUrinary IncontinenceUrinary tract infectionsVaccinologyVascular DisordersViral Infections

SEARCH   News Bookstore Medline The Web Meetings & Congresses Complete Doctor's Guide    EXPLORE :    All News   All Webcasts   All Cases   All Meetings & Congresses   All Medical Resources New drugs / indications English Dictionary Medical Dictionary Thesaurus Warning | Privacy | Awards  Favourite Journals  Click here to choose your favourite journals  Favourite Sites  Click here to choose your favourite sites  Languages  Select languageEnglishFrançais

Australia Approves Tobi (Tobramycin) For Cystic Fibrosis Patients With Pneumonia SEATTLE, WA -- February 23, 2000 -- PathoGenesis Corp. announced that its drug Tobi(R) (tobramycin solution for inhalation) has received marketing clearance from the Therapeutic Goods Administration in Australia. Tobi is indicated for the management of cystic fibrosis patients with Pseudomonas aeruginosa infections, which occur in the lungs. The drug will be distributed by AMRAD Pharmaceuticals Pty. Limited, Victoria, Australia. "Tobi's approval in Australia is excellent news. This is an important market for our inhaled antibiotic as part of our worldwide expansion strategy," said Wilbur H. Gantz, chairman and chief executive officer of PathoGenesis. "AMRAD welcomes the approval of Tobi for Australian cystic fibrosis patients, as it demonstrates the company's proven capability to market innovative new drugs," said Rob Manser, General Manager, AMRAD Pharmaceuticals. Tobi is one of the first drugs to be designated as an orphan drug in Australia. An estimated 2,500 people in Australia have cystic fibrosis, a serious genetic disease that primarily affects Caucasians. Tobi is designed for these patients to take at home in repeated cycles of 28 days on drug, 28 days off drug. It is inhaled twice daily and requires about 15 minutes each time. Seattle-based PathoGenesis Corp. develops and commercializes drugs to treat chronic infectious diseases -- particularly serious lung infections, including those common in cystic fibrosis, bronchiectasis and ventilator patients. AMRAD Corporation Limited is an Australian research-based pharmaceutical and biotechnology company. Based in Melbourne, Victoria, AMRAD conducts research and development to discover and develop innovative medicines. AMRAD Pharmaceuticals Pty. Limited is a joint venture company (55 percent owned by AMRAD, 45 percent owned by Merck Sharp and Dohme (Australia) Pty. Limited) that markets ethical pharmaceuticals to Australian healthcare providers. Related Links: Tobi (tobramycin) and PathoGenesis Corp. E-mail this page to a friend or colleague! To print, use this version